A. Schobel

A. Schobel

Chief Tech/Sci/R&D Officer at AQUESTIVE THERAPEUTICS, INC.

Net worth: 4 M $ as of 2024-03-30

68 year
Health Technology
Process Industries
Technology Services

Profile

A.
Mark Schobel
is currently the Director at Cecilian Partners, LLC.
He is also the Chief Technology & Innovation Officer at Aquestive Therapeutics, Inc. since 2015.
Additionally, he holds the position of Head-Public Relations at MonoSol LLC.
In the past, Mr. Schobel worked as the Principal at Pharmaceutical Formulations, Inc. and Warner-Lambert Co. He was also the Global Head-New Technology at Novartis Corp.
from 2001 to 2005.
Furthermore, he held the position of Principal at Reed & Carnrick Pharmaceuticals.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-03-14 984,476 ( 1.09% ) 4 M $ 2024-03-30

A. Schobel active positions

CompaniesPositionStart
AQUESTIVE THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 2014-10-31
MonoSol LLC /Laundry Bag Business/ Investor Relations Contact -
Director/Board Member -
All active positions of A. Schobel

Former positions of A. Schobel

CompaniesPositionEnd
Corporate Officer/Principal -
Reed & Carnrick Pharmaceuticals Corporate Officer/Principal -
Pharmaceutical Formulations, Inc. Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of A. Schobel's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of A. Schobel's experience

Connections

61

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
AQUESTIVE THERAPEUTICS, INC.

Health Technology

Private companies6
Pharmaceutical Formulations, Inc.

Health Technology

Health Technology

Health Technology

MonoSol LLC /Laundry Bag Business/

Process Industries

Reed & Carnrick Pharmaceuticals

Technology Services

See company connections